Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity

被引：7

作者：

Kraker, Raymond T. ^{[1
]}

Wallace, David K. ^{[2
]}

Beck, Roy W. ^{[1
]}

Saunders, Christina T. ^{[3
]}

Lorenzi, Elizabeth ^{[3
]}

Melia, B. Michele ^{[1
]}

Li, Zhuokai ^{[1
]}

机构：

[1] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA

[2] Indiana Univ, Dept Ophthalmol, Indianapolis, IN 46204 USA

[3] Berry Consultants, Austin, TX USA

来源：

JAMA OPHTHALMOLOGY | 2021年 / 139卷 / 10期

基金：

美国国家卫生研究院;

关键词：

INTRAVITREOUS BEVACIZUMAB;

D O I：

10.1001/jamaophthalmol.2021.3192

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：1143 / 1144

页数：2

共 5 条

[1] Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity [J].

Morin, Julie ;

Thuy Mai Luu ;

Superstein, Rosanne ;

Ospina, Luis H. ;

Lefebvre, Francine ;

Simard, Marie-Noelle ;

Shah, Vibhuti ;

Shah, Prakesh S. ;

Kelly, Edmond N. .

PEDIATRICS, 2016, 137 (04)

[2] Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment [J].

Natarajan, Girija ;

Shankaran, Seetha ;

Nolen, Tracy L. ;

Sridhar, Amaanti ;

Kennedy, Kathleen A. ;

Hintz, Susan R. ;

Phelps, Dale L. ;

DeMauro, Sara B. ;

Carlo, Waldemar A. ;

Gantz, Marie G. ;

Das, Abhik ;

Greenberg, Rachel G. ;

Younge, Noelle E. ;

Bliss, Joseph M. ;

Seabrook, Ruth ;

Sanchez, Pablo J. ;

Wyckoff, Myra H. ;

Bell, Edward F. ;

Vohr, Betty R. ;

Higgins, Rosemary D. .

PEDIATRICS, 2019, 144 (02)

[3] Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity [J].

Wallace, David K. ;

Kraker, Raymond T. ;

Freedman, Sharon F. ;

Crouch, Eric R. ;

Bhatt, Amit R. ;

Hartnett, M. Elizabeth ;

Yang, Michael B. ;

Rogers, David L. ;

Hutchinson, Amy K. ;

VanderVeen, Deborah K. ;

Haider, Kathryn M. ;

Siatkowski, R. Michael ;

Dean, Trevano W. ;

Beck, Roy W. ;

Repka, Michael X. ;

Smith, Lois E. ;

Good, William, V ;

Kong, Lingkun ;

Cotter, Susan A. ;

Holmes, Jonathan M. .

JAMA OPHTHALMOLOGY, 2020, 138 (06) :698-701

[4] Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity A Phase 1 Dosing Study [J].

Wallace, David K. ;

Kraker, Raymond T. ;

Freedman, Sharon F. ;

Crouch, Eric R. ;

Hutchinson, Amy K. ;

Bhatt, Amit R. ;

Rogers, David L. ;

Yang, Michael B. ;

Haider, Kathryn M. ;

VanderVeen, Deborah K. ;

Siatkowski, Michael ;

Dean, Trevano W. ;

Beck, Roy W. ;

Repka, Michael X. ;

Smith, Lois E. ;

Good, William V. ;

Hartnett, Mary Elizabeth ;

Kong, Lingkun ;

Holmes, Jonathan M. .

JAMA OPHTHALMOLOGY, 2017, 135 (06) :654-656

[5] Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity [J].

Wu, Wei-Chi ;

Lien, Reyin ;

Liao, Pei-Ju ;

Wang, Nan-Kai ;

Chen, Yen-Po ;

Chao, An-Ning ;

Chen, Kuan-Jen ;

Chen, Tun-Lu ;

Hwang, Yih-Shiou ;

Lai, Chi-Chun .

JAMA OPHTHALMOLOGY, 2015, 133 (04) :391-397

← 1 →